Ontario man wins OHIP battle for US cancer therapy

AI Summary

An Ontario man with stage 4 melanoma challenged the province after it denied public funding for TIL cancer therapy in Florida, which costs about US$600,000. A court ordered Ontario to reconsider his request, and the province later rejected it again while changing rules for funding out-of-country treatment.

Ontario man Alex Shved, who has Stage 4 melanoma, challenged OHIP after it denied funding for TIL therapy in Florida costing about US$600,000. A court ordered the province to reconsider his request. OHIP later rejected it again, while Ontario changed regulations governing out-of-country drug funding, limiting when patients can receive public coverage abroad.